Question · asked by 1 review

Plasma exchange vs sham exchange: Serious adverse events ‐ not measured

Population
people with CIDP
Intervention
Plasma exchange
Comparison
sham exchange
Outcome
Serious adverse events ‐ not measured

The review found no eligible studies for this question.

What each review found

Current versions only
No studies found 2 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
FindingEffectStudiesGRADE certainty
Plasma exchange vs sham exchange
Serious adverse events ‐ not measured · people with CIDP
The review found no eligible studies for this question.
Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy (2015) · Cochrane Headline outcomes only
no estimate extractedNot reportedNo studies found
Plasma exchange vs sham exchange
Serious adverse events ‐ not measured · patients with CIDP
The review found no eligible studies for this question.
Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy (2012) · Cochrane Headline outcomes onlyearlier version CD003906.PUB3, superseded
no estimate extractedNot reportedNo studies found

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
2015 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.